Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC P-11:0/23:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST002414 AN003935 Mass spectrometry dataset of LC-MS Lipidomics Analysis of Xenopus Laevis Optic Nerve Eye tissue Frog Eye disease University of Miami LC-MS
  logo